LeMaitre Vascular Inc. (NASDAQ:LMAT) insider David B. Roberts sold 6,452 shares of the stock in a transaction that occurred on Friday, September 16th. The stock was sold at an average price of $21.05, for a total value of $135,814.60. Following the transaction, the insider now owns 69,793 shares in the company, valued at $1,469,142.65. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Shares of LeMaitre Vascular Inc. (NASDAQ:LMAT) opened at 21.78 on Wednesday. The company has a 50-day moving average price of $18.61 and a 200-day moving average price of $15.88. LeMaitre Vascular Inc. has a 52-week low of $11.80 and a 52-week high of $22.50. The stock has a market capitalization of $402.15 million, a price-to-earnings ratio of 43.73 and a beta of 0.51.

LeMaitre Vascular (NASDAQ:LMAT) last announced its quarterly earnings results on Wednesday, July 27th. The company reported $0.14 EPS for the quarter, topping the Zacks’ consensus estimate of $0.11 by $0.03. The business had revenue of $22.40 million for the quarter, compared to analysts’ expectations of $21.59 million. LeMaitre Vascular had a return on equity of 11.90% and a net margin of 11.43%. The firm’s revenue for the quarter was up 12.6% compared to the same quarter last year. On average, equities analysts anticipate that LeMaitre Vascular Inc. will post $0.55 earnings per share for the current year.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/lemaitre-vascular-inc-lmat-insider-david-b-roberts-sells-6452-shares.html

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 6th. Shareholders of record on Monday, August 22nd were paid a $0.045 dividend. The ex-dividend date was Thursday, August 18th. This represents a $0.18 dividend on an annualized basis and a yield of 0.83%. LeMaitre Vascular’s dividend payout ratio (DPR) is currently 36.73%.

LMAT has been the topic of a number of research analyst reports. Brean Capital increased their price target on LeMaitre Vascular from $17.50 to $20.00 and gave the stock a “buy” rating in a report on Thursday, July 28th. Barrington Research upped their target price on LeMaitre Vascular from $18.50 to $20.00 and gave the stock an “outperform” rating in a research report on Thursday, July 28th. Canaccord Genuity set a $19.00 target price on LeMaitre Vascular and gave the stock a “buy” rating in a research report on Thursday, July 28th. Finally, Zacks Investment Research lowered LeMaitre Vascular from a “buy” rating to a “hold” rating in a research report on Wednesday, July 6th. Seven investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $18.94.

A number of institutional investors have recently made changes to their positions in the company. Acadian Asset Management LLC boosted its position in shares of LeMaitre Vascular by 44.4% in the first quarter. Acadian Asset Management LLC now owns 184,245 shares of the company’s stock worth $2,860,000 after buying an additional 56,631 shares during the period. Thomson Horstmann & Bryant Inc. acquired a new stake in shares of LeMaitre Vascular during the first quarter worth $3,152,000. BlackRock Institutional Trust Company N.A. raised its stake in shares of LeMaitre Vascular by 18.4% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 216,813 shares of the company’s stock worth $3,365,000 after buying an additional 33,754 shares in the last quarter. Acrospire Investment Management LLC acquired a new stake in shares of LeMaitre Vascular during the first quarter worth $265,000. Finally, State Street Corp raised its stake in shares of LeMaitre Vascular by 4.3% in the first quarter. State Street Corp now owns 297,877 shares of the company’s stock worth $4,623,000 after buying an additional 12,189 shares in the last quarter. 59.88% of the stock is currently owned by institutional investors and hedge funds.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop, manufacture and market medical devices and implants used primarily in the field of vascular surgery. It operates in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.

5 Day Chart for NASDAQ:LMAT

Receive News & Ratings for LeMaitre Vascular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular Inc. and related companies with MarketBeat.com's FREE daily email newsletter.